Cargando…

Antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (HIP) in Uganda; a prospective cohort study

BACKGROUND: Hyperglycaemia in pregnancy (HIP) is associated with complications for both mother and baby. The prevalence of the condition is likely to increase across Africa as the continent undergoes a rapid demographic transition. However, little is known about the management and pregnancy outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Milln, Jack, Nakabuye, Betty, Natamba, Barnabas Kahiira, Sekitoleko, Isaac, Mubiru, Michael, Namara, Arthur Araali, Tumwesigire, Samuel, Tino, Salome, Mirembe, Mandy, Kakande, Ayoub, Agaba, Brian, Nansubuga, Faridah, Zaake, Daniel, Ayiko, Ben, Kalema, Herbert, Nakubulwa, Sarah, Sekikubo, Musa, Nakimuli, Annettee, Webb, Emily L., Nyirenda, Moffat J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132348/
https://www.ncbi.nlm.nih.gov/pubmed/34011299
http://dx.doi.org/10.1186/s12884-021-03795-5
_version_ 1783694895967371264
author Milln, Jack
Nakabuye, Betty
Natamba, Barnabas Kahiira
Sekitoleko, Isaac
Mubiru, Michael
Namara, Arthur Araali
Tumwesigire, Samuel
Tino, Salome
Mirembe, Mandy
Kakande, Ayoub
Agaba, Brian
Nansubuga, Faridah
Zaake, Daniel
Ayiko, Ben
Kalema, Herbert
Nakubulwa, Sarah
Sekikubo, Musa
Nakimuli, Annettee
Webb, Emily L.
Nyirenda, Moffat J.
author_facet Milln, Jack
Nakabuye, Betty
Natamba, Barnabas Kahiira
Sekitoleko, Isaac
Mubiru, Michael
Namara, Arthur Araali
Tumwesigire, Samuel
Tino, Salome
Mirembe, Mandy
Kakande, Ayoub
Agaba, Brian
Nansubuga, Faridah
Zaake, Daniel
Ayiko, Ben
Kalema, Herbert
Nakubulwa, Sarah
Sekikubo, Musa
Nakimuli, Annettee
Webb, Emily L.
Nyirenda, Moffat J.
author_sort Milln, Jack
collection PubMed
description BACKGROUND: Hyperglycaemia in pregnancy (HIP) is associated with complications for both mother and baby. The prevalence of the condition is likely to increase across Africa as the continent undergoes a rapid demographic transition. However, little is known about the management and pregnancy outcomes associated with HIP in the region, particularly less severe forms of hyperglycaemia. It is therefore important to generate local data so that resources may be distributed effectively. The aim of this study was to describe the antenatal management and maternal/fetal outcomes associated with HIP in Ugandan women. METHODS: A prospective cohort study of 2917 pregnant women in five major hospitals in urban/semi-urban central Uganda. Women were screened with oral glucose tolerance test (OGTT) at 24–28 weeks of gestation. Cases of gestational diabetes (GDM) and diabetes in pregnancy (DIP) were identified (WHO 2013 diagnostic criteria) and received standard care. Data was collected on maternal demographics, anthropometrics, antenatal management, umbilical cord c-peptide levels, and pregnancy outcomes. RESULTS: Two hundred and seventy-six women were diagnosed with HIP (237 classified as GDM and 39 DIP). Women had between one and four fasting capillary blood glucose checks during third trimester. All received lifestyle advice, one quarter (69/276) received metformin therapy, and one woman received insulin. HIP was associated with large birthweight (unadjusted relative risk 1.30, 95% CI 1.00–1.68), Caesarean delivery (RR 1.34, 95% CI 1.14–1.57) and neonatal hypoglycaemia (RR 4.37, 95% CI 1.36–14.1), but not perinatal mortality or preterm birth. Pregnancy outcomes were generally worse for women with DIP compared with GDM. CONCLUSION: HIP is associated with significant adverse pregnancy outcomes in this population, particularly overt diabetes in pregnancy. However pregnancy outcomes in women with milder forms of hyperglycaemia are similar to those with normoglycaemic pregnancies. Intervention strategies are required to improve current monitoring and management practice, and more research needed to understand if this is a cost-effective way of preventing poor perinatal outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-021-03795-5.
format Online
Article
Text
id pubmed-8132348
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81323482021-05-19 Antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (HIP) in Uganda; a prospective cohort study Milln, Jack Nakabuye, Betty Natamba, Barnabas Kahiira Sekitoleko, Isaac Mubiru, Michael Namara, Arthur Araali Tumwesigire, Samuel Tino, Salome Mirembe, Mandy Kakande, Ayoub Agaba, Brian Nansubuga, Faridah Zaake, Daniel Ayiko, Ben Kalema, Herbert Nakubulwa, Sarah Sekikubo, Musa Nakimuli, Annettee Webb, Emily L. Nyirenda, Moffat J. BMC Pregnancy Childbirth Research BACKGROUND: Hyperglycaemia in pregnancy (HIP) is associated with complications for both mother and baby. The prevalence of the condition is likely to increase across Africa as the continent undergoes a rapid demographic transition. However, little is known about the management and pregnancy outcomes associated with HIP in the region, particularly less severe forms of hyperglycaemia. It is therefore important to generate local data so that resources may be distributed effectively. The aim of this study was to describe the antenatal management and maternal/fetal outcomes associated with HIP in Ugandan women. METHODS: A prospective cohort study of 2917 pregnant women in five major hospitals in urban/semi-urban central Uganda. Women were screened with oral glucose tolerance test (OGTT) at 24–28 weeks of gestation. Cases of gestational diabetes (GDM) and diabetes in pregnancy (DIP) were identified (WHO 2013 diagnostic criteria) and received standard care. Data was collected on maternal demographics, anthropometrics, antenatal management, umbilical cord c-peptide levels, and pregnancy outcomes. RESULTS: Two hundred and seventy-six women were diagnosed with HIP (237 classified as GDM and 39 DIP). Women had between one and four fasting capillary blood glucose checks during third trimester. All received lifestyle advice, one quarter (69/276) received metformin therapy, and one woman received insulin. HIP was associated with large birthweight (unadjusted relative risk 1.30, 95% CI 1.00–1.68), Caesarean delivery (RR 1.34, 95% CI 1.14–1.57) and neonatal hypoglycaemia (RR 4.37, 95% CI 1.36–14.1), but not perinatal mortality or preterm birth. Pregnancy outcomes were generally worse for women with DIP compared with GDM. CONCLUSION: HIP is associated with significant adverse pregnancy outcomes in this population, particularly overt diabetes in pregnancy. However pregnancy outcomes in women with milder forms of hyperglycaemia are similar to those with normoglycaemic pregnancies. Intervention strategies are required to improve current monitoring and management practice, and more research needed to understand if this is a cost-effective way of preventing poor perinatal outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-021-03795-5. BioMed Central 2021-05-19 /pmc/articles/PMC8132348/ /pubmed/34011299 http://dx.doi.org/10.1186/s12884-021-03795-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Milln, Jack
Nakabuye, Betty
Natamba, Barnabas Kahiira
Sekitoleko, Isaac
Mubiru, Michael
Namara, Arthur Araali
Tumwesigire, Samuel
Tino, Salome
Mirembe, Mandy
Kakande, Ayoub
Agaba, Brian
Nansubuga, Faridah
Zaake, Daniel
Ayiko, Ben
Kalema, Herbert
Nakubulwa, Sarah
Sekikubo, Musa
Nakimuli, Annettee
Webb, Emily L.
Nyirenda, Moffat J.
Antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (HIP) in Uganda; a prospective cohort study
title Antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (HIP) in Uganda; a prospective cohort study
title_full Antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (HIP) in Uganda; a prospective cohort study
title_fullStr Antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (HIP) in Uganda; a prospective cohort study
title_full_unstemmed Antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (HIP) in Uganda; a prospective cohort study
title_short Antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (HIP) in Uganda; a prospective cohort study
title_sort antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (hip) in uganda; a prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132348/
https://www.ncbi.nlm.nih.gov/pubmed/34011299
http://dx.doi.org/10.1186/s12884-021-03795-5
work_keys_str_mv AT millnjack antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT nakabuyebetty antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT natambabarnabaskahiira antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT sekitolekoisaac antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT mubirumichael antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT namaraarthuraraali antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT tumwesigiresamuel antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT tinosalome antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT mirembemandy antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT kakandeayoub antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT agababrian antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT nansubugafaridah antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT zaakedaniel antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT ayikoben antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT kalemaherbert antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT nakubulwasarah antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT sekikubomusa antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT nakimuliannettee antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT webbemilyl antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy
AT nyirendamoffatj antenatalmanagementandmaternalfetaloutcomesassociatedwithhyperglycaemiainpregnancyhipinugandaaprospectivecohortstudy